Corrigendum: Chinese Guidelines for the Diagnosis and Management of Tumefactive Demyelinating Lesions of Central Nervous System.

[This corrects the article DOI: 10.4103/0366-6999.211547.].

In the article titled “Chinese Guidelines for the Diagnosis and Management of Tumefactive Demyelinating Lesions of Central Nervous System”, published in pages 1838-1850, issue 15, vol. 130 of Chinese Medical Journal[1], the figure legend of Figure 6 is written incorrectly. The correct Figure 6 legend should read as following:

Figure 6: In a patient with TDLs, marked elevation of Cho peak value, slight depression of NAA peak value, with Cho/NAA = 1.88, elevation of lactate peak value (TE = 144) and elevation of β, γ Glx peak value were detected on 1H MRS (a). In a patient with anaplastic astrocytoma Grade III, elevation of Cho peak value, depression of NAA peak value, with Cho/NAA = 3.72, and visible lactate peak were detected on 1H MRS (b). In a patient with PCNSL (diffuse large B cell lymphoma), elevation of Cho peak value, with Cho/Cr = 8.0, NAA within normal limit, and high lip peak were detected on 1H MRS (c). TDLs: Tumefactive demyelinating lesions; PCNSL: Primary central nervous system lymphomas; NAA: N acetylarginine.